[1]张 华.支原体肺炎患儿血清中表面活性物质相关蛋白-C水平与肺功能的相关性[J].新乡医学院学报,2017,34(7):630-632.[doi:10.7683/xxyxyxb.2017.07.020]
 ZHANG Hua.Relationship between serum surfactant associated protein-C levels and lung function in children with mycoplasma pneumonia[J].Journal of Xinxiang Medical University,2017,34(7):630-632.[doi:10.7683/xxyxyxb.2017.07.020]
点击复制

支原体肺炎患儿血清中表面活性物质相关蛋白-C水平与肺功能的相关性
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
34
期数:
2017年7
页码:
630-632
栏目:
临床研究
出版日期:
2017-07-05

文章信息/Info

Title:
Relationship between serum surfactant associated protein-C levels and lung function in children with mycoplasma pneumonia
作者:
张 华
(驻马店市第一人民医院小儿内科,河南 驻马店 463000)
Author(s):
ZHANG Hua
(Department of Pediatrics,the First People′s Hospital of Zhumadian City,Zhumadian 463000,Henan Province,China)
关键词:
支原体肺炎表面活性物质相关蛋白-C肺功能儿童
Keywords:
mycoplasma pneumoniasurfactant associated protein-Clung functionchildren
分类号:
R563.1
DOI:
10.7683/xxyxyxb.2017.07.020
文献标志码:
A
摘要:
目的 探讨支原体肺炎(MP)患儿血清中表面活性物质相关蛋白-C(SP-C)水平与肺功能的相关性。方法 选择2015年1月至2016年12月驻马店市第一人民医院收治的MP患儿19例作为MP组,另选择同期体检健康儿童15例作为对照组,采用酶联免疫吸附试验检测2组儿童血清中SP-C水平;抽取左侧桡动脉血行血气分析,测定动脉血氧分压(PaO2)和动脉血二氧化碳分压(PaCO2);检测2组儿童第1秒用力呼气容积(FEV1)和用力肺活量(FVC),评估儿童肺通气功能;比较2组儿童血清SP-C水平、PaO2、PaCO2、FEV1及FVC,并分析MP组患儿血清SP-C水平与PaO2、PaCO2、FEV1、FVC的相关性。结果 MP组儿童PaO2显著低于对照组(P<0.05);2组儿童PaCO2比较差异无统计学意义(P>0.05)。MP组儿童FEV1、FVC及FEV1/FVC显著低于对照组(P<0.05)。MP组和对照组儿童血清SP-C水平分别为(3.92±0.13)、(6.43±0.11)mg·L-1,MP组儿童血清SP-C水平显著低于对照组(t=8.512,P<0.05)。MP患儿血清SP-C水平与PaO2呈正相关(r=0.215,P<0.05),但MP患儿血清SP-C水平与PaCO2无相关性(r=-1.012,P>0.05)。MP患儿血清SP-C水平与FEV1、FVC及FEV1/FVC均呈正相关(r=0.627、0.391、0.472,P<0.05)。结论 MP患儿外周血SP-C水平低于健康儿童,SP-C水平越低,肺功能障碍越严重。检测MP患儿外周血SP-C水平有助于临床医师判断MP患儿的肺损伤和肺功能情况。
Abstract:
Objective To investigate the relationship between serum surfactant associated protein-C (SP-C) levels and lung function in children with mycoplasma pneumonia (MP).Methods Nineteen children with MP from January 2015 to December 2016 in the First People′s Hospital of Zhumadian City were selected as MP group,and fifteen healthy children during the same period were selected as control group.The serum SP-C level was detected by enzyme-linked immunosorbent assay in the two groups.The left radial artery blood was taken for blood gas analysis,and the arterial oxygen partial pressure (PaO2) and arterial carbon dioxide pressure (PaCO2) were detected.The pulmonary ventilation function was assessed by detecting forced expiratory volume (FEV1) and forced vital capacity (FVC) in the two groups.The serum SP-C level,PaO2,PaCO2,FEV1 and FVC were compared between the two groups.The correlation of serum SP-C level with PaO2,PaCO2,FEV1 and FVC in MP children was analyzed.Results The PaO2 in MP group was significantly lower than that in the control group (P<0.05),but there was no significant difference in the PaCO2 between the two groups (P>0.05).The FEV1,FVC and FEV1/FVC of children in MP group were significantly lower than those in the control group (P<0.05).The serum SP-C level in the MP group and control group was (3.92±0.13) and (6.43±0.11) mg·L-1,the serum SP-C level in the MP group was significantly lower than that in the control group (t=8.512,P<0.05).The serum SP-C level was positively correlated with PaO2 in children with MP (r=0.215,P<0.05),but there was no correlation between serum SP-C level and PaCO2 in children with MP (r=-1.012,P>0.05).The serum SP-C level was positively correlated with FEV1,FVC and FEV1/FVC in children with MP (r=0.627,0.391,0.472;P<0.05).Conclusion SP-C level in peripheral blood of children with MP is lower than that in healthy children.The SP-C level is more lower,the pulmonary dysfunction is more serious.The detection of SP-C level in peripheral blood is helpful to determine lung injury and lung function of MP children.

参考文献/References:

[1] MEDJO B,ATANASKOVIC-MARKOVIC M,RADIC S,et al.Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children:clinical features and laboratory diagnosis[J].Ital J Pediatr,2014,40(1):104-110.
[2] 韩金芬,王文秀,王川云,等.布地奈德联合阿奇霉素治疗儿童肺炎支原体肺炎疗效观察[J].新乡医学院学报,2016,33(8):684-685,691.
[3] 孙娜,李东野,李新宇.不同病原体感染的肺炎儿童外周血C-反应蛋白表达水平分析[J].中国医药指南,2013,11(33):409-410.
[4] 韩笑.SP-C基因突变与新生儿呼吸窘迫综合征的关联性研究[D].大连:大连医科大学,2015.
[5] 张艳明,张树英,韦秋芬,等.肺表面活性蛋白C启动子变异与早产儿呼吸窘迫综合征关系的研究[J].广西医科大学学报,2016,33(1):33-35.
[6] 张皓,邬宇芬,黄剑峰,等.儿童肺功能检测及评估专家共识[J].临床儿科杂志,2014,32(2):104-114.
[7] 中华医学会儿科学分会呼吸学组,《中华实用儿科临床杂志》编辑委员会.儿童肺炎支原体肺炎诊治专家共识(2015年版)[J].中华实用儿科临床杂志,2015,30(17):1304-1308.
[8] SALERNO T,PECA D,MENCHINI L,et al.Surfactant protein C-associated interstitial lung disease;three different phenotypes of the same SFTPC mutation[J].Ital J Pediatr,2016,42(1):1-4.
[9] ALMLN A,WALTHER F J,WARING A J,et al.Synthetic surfactant based on analogues of SP-B and SP-C is superior to single-peptide surfactants in ventilated premature rabbits[J].Neonatology,2010,98(1):91-99.
[10] GLASSER S W,SENFT A P,MAXFIELD M D,et al.Genetic replacement of surfactant protein-C reduces respiratory syncytial virus induced lung injury[J].Respir Res,2013,14(1):19.
[11] DENG F T,OUYANG W X,GE L F,et al.Expression of lung surfactant proteins SP-B and SP-C and their modulating factors in fetal lung of FGR rats[J].J Huazhong Univ Sci Technolog (Med Sci),2015,35(1):122-128.
[12] 曲斐斐,谢露,王春枝,等.新生儿呼吸窘迫综合征肺表面活性物质蛋白不同表达水平分析[J].中国新生儿科杂志,2013,8(1):7-11.
[13] 祝晓溪,王超云,朱国青,等.Dlkl、Jaggedl基因在大鼠肺泡Ⅱ型上皮细胞增殖及转分化中的作用[J].中国实用儿科临床杂志,2014,29(9):687-692.
[14] 邓飞涛,张莉,葛凉芳,等.妊娠期糖尿病大鼠的胎鼠肺结构和肺表面活性蛋白B、C及其调控因子表达[J].中华围产医学杂志,2015,18(8):625-632.
[15] 张绍芬,邓继岿,李晶,等.肺炎病儿支气管肺泡灌洗液中PS水平的变化[J].青岛大学医学院学报,2009,45(6):542-544.

相似文献/References:

[1]郑道海,张大琦,许峰.小儿支原体肺炎33例血清学检查结果分析[J].新乡医学院学报,2003,20(02):138.
[2]郑道海,张大琦,许 峰.小儿支原体肺炎33 例血清学检查结果分析[J].新乡医学院学报,2003,20(02):138.
[3]郭红年.阿奇霉素治疗小儿支原体肺炎临床疗效[J].新乡医学院学报,2008,25(01):054.
[4]董 琳.2岁以下儿童支原体肺炎临床特征分析[J].新乡医学院学报,2017,34(6):517.[doi:10.7683/xxyxyxb.2017.06.017]
 DONG Lin.Clinical characteristics of mycoplasma pneumoniae pneumonia in children under two years old[J].Journal of Xinxiang Medical University,2017,34(7):517.[doi:10.7683/xxyxyxb.2017.06.017]
[5]韩金芬,柳晓艳,王会娟.阿奇霉素联合小儿肺热咳喘口服液治疗儿童支原体肺炎疗效观察[J].新乡医学院学报,2016,33(6):483.[doi:10.7683/xxyxyxb.2016.06.010]
 HAN Jin-fen,LIU Xiao-yan,WANG Hui-juan.Effect of azithromycin combined with infantile feirekechuan oral solution for mycoplasma pneumonia in children[J].Journal of Xinxiang Medical University,2016,33(7):483.[doi:10.7683/xxyxyxb.2016.06.010]

更新日期/Last Update: 2017-07-05